Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: aimgator

Feb 24, 2009 04:36AM

Feb 24, 2009 05:19AM

Feb 24, 2009 05:45AM

On September 1, 2008 we purchased Crossflo for $10 million in cash and stock. The average closing price of our common stock as required to be calculated in the Agreement and Plan of Merger was $0.24389 per share

http://www.pinksheets.com/edgar/GetF...







Be well

Share
New Message
Please login to post a reply